Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_assertion type Assertion NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_head.
- NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_assertion description "[Shh and its target transcription factor, Gli1 mRNA, were assessed by RT-PCR and/or quantitative RT-PCR in co-cultured cell recombinants comprised of AI C4-2 either with NPF (prostate fibroblasts from normal/benign prostate gland) or CPF (cancer-associated stromal fibroblasts) under Shh/cyclopamine (a hedgehog signaling inhibitor) treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_provenance.
- NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_assertion evidence source_evidence_literature NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_provenance.
- NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_assertion SIO_000772 21520153 NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_provenance.
- NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_assertion wasDerivedFrom befree-20140225 NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_provenance.
- NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_assertion wasGeneratedBy ECO_0000203 NP920746.RALMhwepHBkauYkU9Y3O_gQopwpJb91IcegSJNQfeN-Zg130_provenance.